# Incyte > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:590d6dea-9be2-46bc-8fbc-41ed972808f7 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/incyte-corp | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 43 | | Claims under review | 1 | | Evidence records | 16 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T13:51:36.651657+00:00 | | Last reviewed | 2026-10-16T13:51:36.651657+00:00 | ## Identity - Legal name: INCYTE CORP - Display name: Incyte ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T16:30:52.10532+00:00 | | Completeness | 0.455 | | Record Quality | 0.837 | | Directors | 9 | | Committees | 8 | | Governance events | 28 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | PUBLISHED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Edmund P. Harrigan, M.D.: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Audit and Finance (member); Science and Technology (chair); Science and Technology · Chair; Audit and Finance (member). claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:10 - Jacqualyn A. Fouse, Ph.D.: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Audit and Finance (member); Audit and Finance; Nominating and Corporate Governance (member); Nominating and Corporate Governance (member). claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:11 - Jean-Jacques Bienaim: Independent Director. Status: current. Independent: true. Since: 2015-01-01. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:12 - Julian C. Baker: Chair. Status: current. Independent: false. Since: 2001-01-01. Committees: Compensation (member); Nominating and Corporate Governance (chair); Nominating and Corporate Governance · Chair; Compensation (chair). claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:9 - Katherine A. High, M.D.: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Science and Technology (member). claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:13 - Otis W. Brawley: Independent Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Science and Technology (member). claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:14 - Paul J. Clancy: Independent Director. Status: current. Independent: true. Since: 2015-01-01. Committees: Audit and Finance (chair); Audit and Finance · Chair; Compensation (member); Compensation (member). claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:15 - William J. Meury: Director. Status: current. Independent: false. Since: 2025-01-01. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:16 - Susanne Schaffert, Ph.D.: Director (committee appointment). Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. Committees: Compensation (member). claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_record:32 ## Committees - Audit and Finance (audit). Chair: Paul J. Clancy. Members: Paul J. Clancy (chair, current); Edmund P. Harrigan, M.D. (member, current); Jacqualyn A. Fouse, Ph.D. (member, current). committee_id=alpha:committee:incyte-corp:audit-and-finance - Audit and Finance · Chair; Compensation (audit). Chair: NOT_PUBLISHED. Members: Paul J. Clancy (member, current). committee_id=alpha:committee:incyte-corp:audit-and-finance-chair-compensation - Audit and Finance; Nominating and Corporate Governance (audit). Chair: NOT_PUBLISHED. Members: Jacqualyn A. Fouse, Ph.D. (member, current). committee_id=alpha:committee:incyte-corp:audit-and-finance-nominating-and-corporate-governance - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Julian C. Baker (member, current); Paul J. Clancy (member, current); Susanne Schaffert, Ph.D. (member, current). committee_id=alpha:committee:incyte-corp:compensation - Nominating and Corporate Governance (nominating_governance). Chair: Julian C. Baker. Members: Julian C. Baker (chair, current); Jacqualyn A. Fouse, Ph.D. (member, current). committee_id=alpha:committee:incyte-corp:nominating-and-corporate-governance - Nominating and Corporate Governance · Chair; Compensation (compensation). Chair: Julian C. Baker. Members: Julian C. Baker (chair, current). committee_id=alpha:committee:incyte-corp:nominating-and-corporate-governance-chair-compensation - Science and Technology (technology). Chair: Edmund P. Harrigan, M.D.. Members: Edmund P. Harrigan, M.D. (chair, current); Katherine A. High, M.D. (member, current); Otis W. Brawley (member, current). committee_id=alpha:committee:incyte-corp:science-and-technology - Science and Technology · Chair; Audit and Finance (audit). Chair: NOT_PUBLISHED. Members: Edmund P. Harrigan, M.D. (member, current). committee_id=alpha:committee:incyte-corp:science-and-technology-chair-audit-and-finance ## Executive leadership - David Gardner: Executive Vice President and Chief Strategy Officer. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:17 - Lee Heeson: Executive Vice President, Incyte International. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:18 - Matteo Trotta: Executive Vice President, General Manager, Dermatology US. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:19 - Michael Morrissey: Executive Vice President and Head of Global Technical Operations. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:20 - Mohamed Issa: Executive Vice President, Head of US Oncology. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:21 - Pablo J. Cagnoni: President and Head of Research and Development [PRESIDENT]. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:22 - Reid G. Hoffman: Executive Vice President and General Counsel [GC]. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:23 - Soni Basi: Executive Vice President and Chief Human Resources Officer [CHRO]. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:25 - Steven Stein: Executive Vice President and Chief Medical Officer. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:26 - William J. Meury: President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:27 - Richard Hoffman: Executive Vice President and General Counsel [GC]. Status: unknown. claim_id=alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:24 ## Governance events - EXECUTIVE_APPOINTED: David Gardner executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:l0rk0u1v7xpd8 - EXECUTIVE_APPOINTED: Lee Heeson executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1hqnhjb16zyhm1 - EXECUTIVE_APPOINTED: Matteo Trotta executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1wq6k72zotzxq - EXECUTIVE_APPOINTED: Michael Morrissey executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:10zo14k1oyvw96 - EXECUTIVE_APPOINTED: Mohamed Issa executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1l5rubq13wvvza - EXECUTIVE_APPOINTED: Pablo J. Cagnoni executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1xze6qs1t8xu1m - GC_CHANGED: Reid G. Hoffman executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:wtfemy15dtqs - EXECUTIVE_APPOINTED: Soni Basi executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1xljo607fkweq - EXECUTIVE_APPOINTED: Steven Stein executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:12vxect4t347p - CEO_CHANGED: William J. Meury executive of Incyte, effective 2026-02-10. Effective: 2026-02-10. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:121ciesypmsqe - DIRECTOR_APPOINTED: William J. Meury seat on Incyte, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:amgx6q16jq02i - DIRECTOR_APPOINTED: Otis W. Brawley seat on Incyte, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:l64despqlxw4 - DIRECTOR_APPOINTED: Katherine A. High, M.D. seat on Incyte, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:sqiwq0n2i4dq - COMMITTEE_MEMBER_ADDED: Katherine A. High, M.D. member of Science and Technology, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:efnuys13gbchy - DIRECTOR_APPOINTED: Edmund P. Harrigan, M.D. seat on Incyte, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:4dch191px262f - COMMITTEE_CREATED: Science and Technology · Chair; Audit and Finance committee of Incyte, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1csrpkx15v9rwv - COMMITTEE_MEMBER_ADDED: Edmund P. Harrigan, M.D. member of Science and Technology · Chair; Audit and Finance, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1p9y2b7ns59b5 - DIRECTOR_APPOINTED: Jacqualyn A. Fouse, Ph.D. seat on Incyte, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1v4ky2waxtwm4 - COMMITTEE_CREATED: Audit and Finance; Nominating and Corporate Governance committee of Incyte, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1o3vjpw10ag2s - COMMITTEE_MEMBER_ADDED: Jacqualyn A. Fouse, Ph.D. member of Audit and Finance; Nominating and Corporate Governance, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:1yi5jhw1pxaz3q - DIRECTOR_APPOINTED: Jean-Jacques Bienaim seat on Incyte, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:141br331ea9hbl - DIRECTOR_APPOINTED: Paul J. Clancy seat on Incyte, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:172vvxyaxv0ai - COMMITTEE_CREATED: Audit and Finance · Chair; Compensation committee of Incyte, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:40k85e1cy0yy2 - COMMITTEE_MEMBER_ADDED: Paul J. Clancy member of Audit and Finance · Chair; Compensation, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:q7jfubiz08lp - DIRECTOR_APPOINTED: Julian C. Baker seat on Incyte, effective 2001-01-01. Effective: 2001-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:hpiidi1g8sfbu - BOARD_CHAIR_CHANGED: Julian C. Baker chairs board Incyte, effective 2001-01-01. Effective: 2001-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:v162vw1nhwgza - COMMITTEE_CREATED: Nominating and Corporate Governance · Chair; Compensation committee of Incyte, effective 2001-01-01. Effective: 2001-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:7lojp07i6jna - COMMITTEE_CHAIR_CHANGED: Julian C. Baker chairs Nominating and Corporate Governance · Chair; Compensation, effective 2001-01-01. Effective: 2001-01-01. Detected: 2026-10-16T13:51:36.651657+00:00. event_id=alpha:event:transition:qxrue613rzjpu ## Scoped resources - `alpha://company/incyte-corp` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record - `alpha://company/incyte-corp/identity` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=identity - `alpha://company/incyte-corp/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=corporate-structure - `alpha://company/incyte-corp/board` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=board - `alpha://company/incyte-corp/committees` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=committees - `alpha://company/incyte-corp/leadership` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=leadership - `alpha://company/incyte-corp/ownership` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=ownership - `alpha://company/incyte-corp/financials` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=financials - `alpha://company/incyte-corp/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=capital-structure - `alpha://company/incyte-corp/compensation` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=compensation - `alpha://company/incyte-corp/governance` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=governance - `alpha://company/incyte-corp/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=shareholder-governance - `alpha://company/incyte-corp/audit` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=audit - `alpha://company/incyte-corp/legal` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=legal - `alpha://company/incyte-corp/risk` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=risk - `alpha://company/incyte-corp/cyber` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=cyber - `alpha://company/incyte-corp/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=ai-governance - `alpha://company/incyte-corp/agents` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=agents - `alpha://company/incyte-corp/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=ecosystem - `alpha://company/incyte-corp/events` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=events - `alpha://company/incyte-corp/relationships` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=relationships - `alpha://company/incyte-corp/assessments` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=assessments - `alpha://company/incyte-corp/evidence` (contract): https://registry.alpha.ac/api/public/companies/incyte-corp?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:29: `{"kind":"committee_appointment","original_name":"Audit and Finance","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:paul-j-clancy","name":"Paul J. Clancy"},"source_id":"board_seats"}` - Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:30: `{"kind":"committee_appointment","original_name":"Audit and Finance","category":"audit","role":"member","person":{"alpha_id":"alpha:person:edmund-p-harrigan-md","name":"Edmund P. Harrigan, M.D."},"source_id":"board_seats"}` - Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:31: `{"kind":"committee_appointment","original_name":"Audit and Finance","category":"audit","role":"member","person":{"alpha_id":"alpha:person:jacqualyn-a-fouse-phd","name":"Jacqualyn A. Fouse, Ph.D."},"source_id":"board_seats"}` - Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:33: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:julian-c-baker","name":"Julian C. Baker"},"source_id":"board_seats"}` - Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:34: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:paul-j-clancy","name":"Paul J. Clancy"},"source_id":"board_seats"}` - Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:35: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:susanne-schaffert-phd","name":"Susanne Schaffert, Ph.D."},"source_id":"board_seats"}` - Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:37: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:julian-c-baker","name":"Julian C. Baker"},"source_id":"board_seats"}` - Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:38: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:jacqualyn-a-fouse-phd","name":"Jacqualyn A. Fouse, Ph.D."},"source_id":"board_seats"}` - Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:40: `{"kind":"committee_appointment","original_name":"Science and Technology","category":"technology","role":"chair","person":{"alpha_id":"alpha:person:edmund-p-harrigan-md","name":"Edmund P. Harrigan, M.D."},"source_id":"board_seats"}` - Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:41: `{"kind":"committee_appointment","original_name":"Science and Technology","category":"technology","role":"member","person":{"alpha_id":"alpha:person:katherine-a-high-md","name":"Katherine A. High, M.D."},"source_id":"board_seats"}` - Claim alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:42: `{"kind":"committee_appointment","original_name":"Science and Technology","category":"technology","role":"member","person":{"alpha_id":"alpha:person:otis-w-brawley","name":"Otis W. Brawley"},"source_id":"board_seats"}` ## Leadership - Julian C. Baker: Chair, Nominating and Corporate Governance · Chair; Compensation. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:9. Valid from: 2001-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6b5fe7cd264d2c97859641abe6627e404142155a3b752ca81e02401f790a0d28. - Edmund P. Harrigan, M.D.: Director, Science and Technology · Chair; Audit and Finance. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:10. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6b5fe7cd264d2c97859641abe6627e404142155a3b752ca81e02401f790a0d28. - Jacqualyn A. Fouse, Ph.D.: Director, Audit and Finance; Nominating and Corporate Governance. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:11. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6b5fe7cd264d2c97859641abe6627e404142155a3b752ca81e02401f790a0d28. - Jean-Jacques Bienaim: Independent Director. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:12. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6b5fe7cd264d2c97859641abe6627e404142155a3b752ca81e02401f790a0d28. - Katherine A. High, M.D.: Director, Science and Technology. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:13. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6b5fe7cd264d2c97859641abe6627e404142155a3b752ca81e02401f790a0d28. - Otis W. Brawley: Independent Director, Science and Technology. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:14. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6b5fe7cd264d2c97859641abe6627e404142155a3b752ca81e02401f790a0d28. - Paul J. Clancy: Independent Director, Audit and Finance · Chair; Compensation. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:15. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6b5fe7cd264d2c97859641abe6627e404142155a3b752ca81e02401f790a0d28. - William J. Meury: Director. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:16. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6b5fe7cd264d2c97859641abe6627e404142155a3b752ca81e02401f790a0d28. - David Gardner: Executive Vice President and Chief Strategy Officer. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:17. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:19f1fdfd1ee09449cf6ef33c48f330ec2ed6d0c82ba2af5b2e0ebbe3c5c03166. - Lee Heeson: Executive Vice President, Incyte International. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:18. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5d72178e5acd07aa1b3af0ba6ee37f8cdd0ec941159c4f328a0ec0f0e279eb3b. - Matteo Trotta: Executive Vice President, General Manager, Dermatology US. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:19. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5f087e9b492de92b63909fcbf886cbc0d603e869872a80e4e47897937413f872. - Michael Morrissey: Executive Vice President and Head of Global Technical Operations. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:20. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cca17f96a15a91fa76387c8abaf889e19cf0e8c6beda7681e223c1ba5fd48d0e. - Mohamed Issa: Executive Vice President, Head of US Oncology. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:21. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:eadb8394e7c5c0fe4a637268f2e0e5bbce8cb3a1420d67882ff98ef8caaddc9d. - Pablo J. Cagnoni: President and Head of Research and Development. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:22. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3b19e74569bb098ce52a5e6fc598f6c167b0ff10ae9c1c82337e452d0a83fc84. - Reid G. Hoffman: Executive Vice President and General Counsel. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:23. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a1791f61d598804fb43f93575c55243d952a18ce1eb644507d3b08874590be8c. - Richard Hoffman: Executive Vice President and General Counsel. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:df47b510d310a673fcd2e632e54310a5f44246d1af1676fc9161ce64adcc9458. - Soni Basi: Executive Vice President and Chief Human Resources Officer. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:25. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:77dec150864caa31feb00354e2e71a80fac1c5d03af75f5d5336283c9229f85c. - Steven Stein: Executive Vice President and Chief Medical Officer. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:26. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:802f4ccba8f7ec17c7c5144efbb0f6b31db4252ca74747fd864d4116ae22995c. - William J. Meury: President and Chief Executive Officer. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:leadership_role:27. Valid from: 2026-02-10. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:ca0626aeb5750f9f29106e069106b2b16e440dcb5f6aaf1f66b1aa6f62b5cdf3. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit and Finance: Chair Paul J. Clancy; Members Paul J. Clancy (Chair); Edmund P. Harrigan, M.D.; Jacqualyn A. Fouse, Ph.D.. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_record:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325. - Compensation: Chair not stated; Members Julian C. Baker; Paul J. Clancy; Susanne Schaffert, Ph.D.. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_record:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325. - Nominating and Corporate Governance: Chair Julian C. Baker; Members Julian C. Baker (Chair); Jacqualyn A. Fouse, Ph.D.. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_record:36. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325. - Science and Technology: Chair Edmund P. Harrigan, M.D.; Members Edmund P. Harrigan, M.D. (Chair); Katherine A. High, M.D.; Otis W. Brawley. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_record:39. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - S&P 500 (SPX). Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:index_membership:43. Valid from: 2017-02-28. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:827a22a1567eda11fa866650563f33918ee2975144378fa7fd6f46399da5427a. ## Legal Name - INCYTE CORP. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ea56fd0c183e351bb42f2a564927b7db48ed75d23e5c57d9a5322f07a22fb55. ## Entity Status - Public listing published. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ea56fd0c183e351bb42f2a564927b7db48ed75d23e5c57d9a5322f07a22fb55. ## Official Website - https://www.incyte.com. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:official_website:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7bc3dc35da3c0a2209c493dc6566128ac682e8b3329f7a032b473eb48297de70. ## Published Fact - US. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ea56fd0c183e351bb42f2a564927b7db48ed75d23e5c57d9a5322f07a22fb55. - DE. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ea56fd0c183e351bb42f2a564927b7db48ed75d23e5c57d9a5322f07a22fb55. - Healthcare. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:published_fact:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ea56fd0c183e351bb42f2a564927b7db48ed75d23e5c57d9a5322f07a22fb55. - https://www.incyte.com. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:published_fact:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:7bc3dc35da3c0a2209c493dc6566128ac682e8b3329f7a032b473eb48297de70. ## Committee Appointment - Paul J. Clancy: chair, Audit and Finance. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325. - Edmund P. Harrigan, M.D.: member, Audit and Finance. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325. - Jacqualyn A. Fouse, Ph.D.: member, Audit and Finance. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325. - Julian C. Baker: member, Compensation. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325. - Paul J. Clancy: member, Compensation. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:34. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325. - Susanne Schaffert, Ph.D.: member, Compensation. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:35. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325. - Julian C. Baker: chair, Nominating and Corporate Governance. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:37. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325. - Jacqualyn A. Fouse, Ph.D.: member, Nominating and Corporate Governance. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:38. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325. - Edmund P. Harrigan, M.D.: chair, Science and Technology. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:40. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325. - Katherine A. High, M.D.: member, Science and Technology. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:41. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325. - Otis W. Brawley: member, Science and Technology. Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:committee_appointment:42. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325. ## Security Listing - INCY (NASDAQ). Claim: alpha:claim:company:590d6dea-9be2-46bc-8fbc-41ed972808f7:security_listing:44. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0ea56fd0c183e351bb42f2a564927b7db48ed75d23e5c57d9a5322f07a22fb55. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:0ea56fd0c183e351bb42f2a564927b7db48ed75d23e5c57d9a5322f07a22fb55: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/incyte-corp). - alpha:projection-evidence:7bc3dc35da3c0a2209c493dc6566128ac682e8b3329f7a032b473eb48297de70: [INCYTE CORP Form 10-K (filed 2026-02-10)](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm). - alpha:projection-evidence:document:6b5fe7cd264d2c97859641abe6627e404142155a3b752ca81e02401f790a0d28: [Incyte Corporation DEF 14A 2026-04-28](https://www.sec.gov/Archives/edgar/data/879169/000087916926000031/incy-20260428.htm). - alpha:projection-evidence:document:19f1fdfd1ee09449cf6ef33c48f330ec2ed6d0c82ba2af5b2e0ebbe3c5c03166: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm). - alpha:projection-evidence:document:5d72178e5acd07aa1b3af0ba6ee37f8cdd0ec941159c4f328a0ec0f0e279eb3b: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm). - alpha:projection-evidence:document:5f087e9b492de92b63909fcbf886cbc0d603e869872a80e4e47897937413f872: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm). - alpha:projection-evidence:document:cca17f96a15a91fa76387c8abaf889e19cf0e8c6beda7681e223c1ba5fd48d0e: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm). - alpha:projection-evidence:document:eadb8394e7c5c0fe4a637268f2e0e5bbce8cb3a1420d67882ff98ef8caaddc9d: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm). - alpha:projection-evidence:document:3b19e74569bb098ce52a5e6fc598f6c167b0ff10ae9c1c82337e452d0a83fc84: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm). - alpha:projection-evidence:document:a1791f61d598804fb43f93575c55243d952a18ce1eb644507d3b08874590be8c: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm). - alpha:projection-evidence:document:df47b510d310a673fcd2e632e54310a5f44246d1af1676fc9161ce64adcc9458: INCY executive roster source. - alpha:projection-evidence:document:77dec150864caa31feb00354e2e71a80fac1c5d03af75f5d5336283c9229f85c: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm). - alpha:projection-evidence:document:802f4ccba8f7ec17c7c5144efbb0f6b31db4252ca74747fd864d4116ae22995c: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm). - alpha:projection-evidence:document:ca0626aeb5750f9f29106e069106b2b16e440dcb5f6aaf1f66b1aa6f62b5cdf3: [INCY 10-K executive officers](https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm). - alpha:projection-evidence:dcf94396c4bb63a71ff0e96386f0eb1fe9596b61e947e642839cd1d49faf4325: [Audit and Finance](https://www.sec.gov/Archives/edgar/data/879169/000087916926000031/incy-20260428.htm). - alpha:projection-evidence:827a22a1567eda11fa866650563f33918ee2975144378fa7fd6f46399da5427a: [S&P 500](https://www.slickcharts.com/sp500). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/incyte-corp) - [Public Markdown](https://registry.alpha.ac/companies/incyte-corp.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/incyte-corp?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/incyte-corp?format=jsonld) - MCP resource: `alpha://companies/incyte-corp` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T16:30:51.862436+00:00; recorded 2026-10-16T16:30:51.862436+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.